These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 16785989)

  • 1. Cooperation of oncogenic K-ras and p53 deficiency in pleomorphic rhabdomyosarcoma development in adult mice.
    Tsumura H; Yoshida T; Saito H; Imanaka-Yoshida K; Suzuki N
    Oncogene; 2006 Dec; 25(59):7673-9. PubMed ID: 16785989
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A mouse model for tumor progression of lung cancer in ras and p53 transgenic mice.
    Wang Y; Zhang Z; Lubet RA; You M
    Oncogene; 2006 Feb; 25(8):1277-80. PubMed ID: 16247444
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Knock-in of mutant K-ras in nontumorigenic human epithelial cells as a new model for studying K-ras mediated transformation.
    Konishi H; Karakas B; Abukhdeir AM; Lauring J; Gustin JP; Garay JP; Konishi Y; Gallmeier E; Bachman KE; Park BH
    Cancer Res; 2007 Sep; 67(18):8460-7. PubMed ID: 17875684
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of rhabdomyosarcoma in HER-2/neu transgenic p53 mutant mice.
    Nanni P; Nicoletti G; De Giovanni C; Croci S; Astolfi A; Landuzzi L; Di Carlo E; Iezzi M; Musiani P; Lollini PL
    Cancer Res; 2003 Jun; 63(11):2728-32. PubMed ID: 12782574
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Rhabdomyosarcoma development in Trp53/fos mutant mice: tumor suppressor functions of the Fos protooncogene].
    Jochum W
    Verh Dtsch Ges Pathol; 2004; 88():224-30. PubMed ID: 16892556
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Brain cancer stem-like cell genesis from p53-deficient mouse astrocytes by oncogenic Ras.
    Lee JS; Gil JE; Kim JH; Kim TK; Jin X; Oh SY; Sohn YW; Jeon HM; Park HJ; Park JW; Shin YJ; Chung YG; Lee JB; You S; Kim H
    Biochem Biophys Res Commun; 2008 Jan; 365(3):496-502. PubMed ID: 18021740
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Establishment of a novel experimental system using single cell-derived pleomorphic rhabdomyosarcoma cell lines expressing K-RasG12V and deficient in p53.
    Saito H; Suzuki N
    Exp Anim; 2023 Nov; 72(4):446-453. PubMed ID: 37081671
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genome-wide SNP analysis of Tg.AC transgenic mice reveals an oncogenic collaboration between v-Ha-ras and Ink4a, which is absent in p53 deficiency.
    Leder A; McMenamin J; Zhou F; Moran JL; Beier DR; Leder P
    Oncogene; 2008 Apr; 27(17):2456-65. PubMed ID: 17952114
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Conditional expression of mutated K-ras accelerates intestinal tumorigenesis in Msh2-deficient mice.
    Luo F; Brooks DG; Ye H; Hamoudi R; Poulogiannis G; Patek CE; Winton DJ; Arends MJ
    Oncogene; 2007 Jun; 26(30):4415-27. PubMed ID: 17297472
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The K-Ras 4A isoform promotes apoptosis but does not affect either lifespan or spontaneous tumor incidence in aging mice.
    Plowman SJ; Arends MJ; Brownstein DG; Luo F; Devenney PS; Rose L; Ritchie AM; Berry RL; Harrison DJ; Hooper ML; Patek CE
    Exp Cell Res; 2006 Jan; 312(1):16-26. PubMed ID: 16271715
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Point mutations of N-ras oncogene and abnormal expression of rasp21, p53 proteins in orbital rhabdomyosarcoma].
    Zhang H; Song G; Zhang S; Chang J; Zhang W; Yu H
    Zhonghua Yan Ke Za Zhi; 2000 Jul; 36(4):267-9, 16. PubMed ID: 11853610
    [TBL] [Abstract][Full Text] [Related]  

  • 12. p53 family members in myogenic differentiation and rhabdomyosarcoma development.
    Cam H; Griesmann H; Beitzinger M; Hofmann L; Beinoraviciute-Kellner R; Sauer M; Hüttinger-Kirchhof N; Oswald C; Friedl P; Gattenlöhner S; Burek C; Rosenwald A; Stiewe T
    Cancer Cell; 2006 Oct; 10(4):281-93. PubMed ID: 17045206
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human p53 knock-in (hupki) mice do not differ in liver tumor response from their counterparts with murine p53.
    Jaworski M; Hailfinger S; Buchmann A; Hergenhahn M; Hollstein M; Ittrich C; Schwarz M
    Carcinogenesis; 2005 Oct; 26(10):1829-34. PubMed ID: 15917304
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Profiling of transcripts and proteins modulated by K-ras oncogene in the lung tissues of K-ras transgenic mice by omics approaches.
    Lee S; Kang J; Cho M; Seo E; Choi H; Kim E; Kim J; Kim H; Kang GY; Kim KP; Park YH; Yu DY; Yum YN; Park SN; Yoon DY
    Int J Oncol; 2009 Jan; 34(1):161-72. PubMed ID: 19082487
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical significance of p53, K-ras and DCC gene alterations in the stage I-II colorectal cancers.
    Akkiprik M; Ataizi-Celikel C; Düşünceli F; Sönmez O; Gulluoglu BM; Sav A; Ozer A
    J Gastrointestin Liver Dis; 2007 Mar; 16(1):11-7. PubMed ID: 17410283
    [TBL] [Abstract][Full Text] [Related]  

  • 16. K-Ras promotes growth transformation and invasion of immortalized human pancreatic cells by Raf and phosphatidylinositol 3-kinase signaling.
    Campbell PM; Groehler AL; Lee KM; Ouellette MM; Khazak V; Der CJ
    Cancer Res; 2007 Mar; 67(5):2098-106. PubMed ID: 17332339
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transgenic model of cardiac rhabdomyosarcoma formation.
    Köbbert C; Möllmann C; Schäfers M; Hermann S; Baba HA; Hoffmeier A; Breithardt G; Scheld HH; Weissen-Plenz G; Sindermann JR
    J Thorac Cardiovasc Surg; 2008 Nov; 136(5):1178-86. PubMed ID: 19026800
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Loss of p53 enhances the induction of colitis-associated neoplasia by dextran sulfate sodium.
    Chang WC; Coudry RA; Clapper ML; Zhang X; Williams KL; Spittle CS; Li T; Cooper HS
    Carcinogenesis; 2007 Nov; 28(11):2375-81. PubMed ID: 17557903
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemoprevention of spontaneous tumorigenesis in p53-knockout mice.
    Hursting SD; Perkins SN; Haines DC; Ward JM; Phang JM
    Cancer Res; 1995 Sep; 55(18):3949-53. PubMed ID: 7664260
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Loss of p53 and MCT-1 overexpression synergistically promote chromosome instability and tumorigenicity.
    Kasiappan R; Shih HJ; Chu KL; Chen WT; Liu HP; Huang SF; Choy CO; Shu CL; Din R; Chu JS; Hsu HL
    Mol Cancer Res; 2009 Apr; 7(4):536-48. PubMed ID: 19372582
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.